Simone Hornemann, PhD, completed her doctorate at the Institute of Molecular Biology and Biophysics, ETH Zurich, Switzerland, in the field of prion diseases and was awarded with the ETH medal for an outstanding doctoral dissertation. Her work was the basis for the first three-dimensional structure determination of the prion protein. Between 2001 and 2008, Hornemann was employed as a senior researcher in the laboratory of Professor Kurt Wüthrich (Nobel Prize Laureate in Chemistry, 2002) at the ETH Zurich. During this time, she continued her work on the biophysical and structural characterization of prion proteins. In 2009, Hornemann joined the Institute of Neuropathology, University of Zurich, Switzerland. Her current research focuses on the study of the molecular mechanisms and pathogenesis of neurodegenerative diseases, especially of prion and Parkinson’s disease. She also aims at the development of novel strategies and technologies, such as digital droplet microfluidics, to enable the sensitive diagnosis of neurodegenerative diseases and on the design of novel protein-based strategies for their targeted therapy.